Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP396968.RAMTc38Hykqn5aI-ypvD2UTAsuuYy32va8HAgGfOVOQF0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP396968.RAMTc38Hykqn5aI-ypvD2UTAsuuYy32va8HAgGfOVOQF0130_assertion type Assertion NP396968.RAMTc38Hykqn5aI-ypvD2UTAsuuYy32va8HAgGfOVOQF0130_head.
- NP396968.RAMTc38Hykqn5aI-ypvD2UTAsuuYy32va8HAgGfOVOQF0130_assertion description "[(i) Like normal kidney, virtually all primary human renal cell carcinomas express MHC class I antigens and retain this phenotype even during tumor progression and metastasis; (ii) class II expression on normal and RCC cells appears more limited but occurs frequently in both primary and metastatic lesions; and (iii) in most continuous RCC cell lines expression of MHC class I and II can effectively be stimulated by IFN-gamma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP396968.RAMTc38Hykqn5aI-ypvD2UTAsuuYy32va8HAgGfOVOQF0130_provenance.
- NP396968.RAMTc38Hykqn5aI-ypvD2UTAsuuYy32va8HAgGfOVOQF0130_assertion evidence source_evidence_literature NP396968.RAMTc38Hykqn5aI-ypvD2UTAsuuYy32va8HAgGfOVOQF0130_provenance.
- NP396968.RAMTc38Hykqn5aI-ypvD2UTAsuuYy32va8HAgGfOVOQF0130_assertion SIO_000772 7490887 NP396968.RAMTc38Hykqn5aI-ypvD2UTAsuuYy32va8HAgGfOVOQF0130_provenance.
- NP396968.RAMTc38Hykqn5aI-ypvD2UTAsuuYy32va8HAgGfOVOQF0130_assertion wasDerivedFrom befree-20140225 NP396968.RAMTc38Hykqn5aI-ypvD2UTAsuuYy32va8HAgGfOVOQF0130_provenance.
- NP396968.RAMTc38Hykqn5aI-ypvD2UTAsuuYy32va8HAgGfOVOQF0130_assertion wasGeneratedBy ECO_0000203 NP396968.RAMTc38Hykqn5aI-ypvD2UTAsuuYy32va8HAgGfOVOQF0130_provenance.